Large-scale testing (Phase 3)Not Yet RecruitingNCT05249556
What this trial is testing
Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old
Who this might be right for
CDKL5 Deficiency Disorder
Immedica Pharma AB 20